The FDA is also trying to figure out how to do a trial like this. Few Doctors were staying a few study’s or trials will start this year but I believe they FDA is in the process of figuring out how to approach it. As in what are good end points are ect.

I know its up to us as far as presenting trial design but from what I’ve gathered is that it’s still super early to start a trial in long Covid. I think we will start it just a matter of getting the ok from the FDA.